Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients

NCT00354978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: 5-Fluorouracil
DRUG: Bevacizumab
DRUG: Leucovorin
DRUG: Irinotecan

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]